What Is the ProLon FMD and How Does It Work?

ProLon is a five-day, plant-based meal program designed to give your body the metabolic benefits of a prolonged fast while still allowing you to eat. Developed from decades of research at the University of Southern California’s Longevity Institute, it provides between roughly 770 and 1,100 calories per day in carefully calibrated ratios of fats, carbohydrates, and protein. The goal is to keep nutrient-sensing pathways in your cells switched to “fasting mode” even though food is coming in, a concept researchers call a fasting-mimicking diet, or FMD. The science behind it touches on everything from cellular cleanup to stem cell regeneration, and a growing body of clinical trials is testing whether those laboratory findings hold up in real people.

What You Actually Eat for Five Days

ProLon ships as a box containing five days’ worth of pre-packaged food. Day one provides roughly 1,100 calories, while days two through five drop to about 770 calories each. The macronutrient split is high in unsaturated fats, moderate in complex carbohydrates, and deliberately low in protein. You get things like plant-based soups, olives, kale crackers, nut bars, herbal teas, and a glycerol-based energy drink. The specific formulation matters because it is the macro and micronutrient ratios, not just the calorie count, that keep the body’s key nutrient sensors from recognizing that food has arrived.

The protocol is typically done once a month for three consecutive months, then shifted to a maintenance schedule of once every few months or as needed. During the five days, you eat only what comes in the box. After the five days, you ease back into normal eating over a day or two rather than jumping straight to your usual diet. That refeeding window turns out to be biologically important, as much of the regenerative benefit appears to happen during the transition back to regular nutrition.

How the Diet Tricks Your Body Into Fasting Mode

When you stop eating entirely, your body responds with a cascade of metabolic shifts: blood glucose and insulin drop, growth-signaling hormones like insulin-like growth factor 1 (IGF-1) fall, and your cells switch from growth mode to a protective, repair-oriented state. The challenge with a water-only fast lasting three or more days is that it is difficult, potentially risky for some people, and hard to sustain repeatedly. The FMD was engineered to trigger those same metabolic switches by keeping protein and sugar intake low enough that the body’s nutrient sensors, particularly pathways involving IGF-1, insulin signaling, and a growth-regulating protein called mTOR, remain suppressed.

A mouse study comparing intermittent fasting to the fasting-mimicking diet found that the FMD produced slightly greater weight loss, lower glucose levels, and higher levels of ketone bodies, free fatty acids, and the fasting-associated hormone FGF21 compared to a standard intermittent-fasting schedule.

In practical terms, this means the FMD appears to push the body into a deeper fasting state than typical intermittent fasting regimens that cycle between eating and not eating within a single day. It also distinguishes itself from chronic calorie restriction, which people find notoriously hard to maintain long-term, and from water-only fasting, which carries more safety concerns, especially for people who are ill.

Autophagy and Cellular Cleanup

One of the most talked-about effects of prolonged fasting is autophagy, the process by which cells break down and recycle their own damaged components. Think of it as a deep-cleaning cycle for your cells. Under normal, well-fed conditions, autophagy runs at a low baseline. When nutrient signaling drops, cells ramp up this recycling to scavenge energy and clear out dysfunctional proteins and organelles.

A randomized trial measuring autophagy markers in humans found that subjects on a six-day FMD showed improved autophagic flux along with reductions in body weight, fasting glucose, and insulin resistance compared to a control group eating normally.

A separate randomized study tested two versions of the FMD with different protein levels and found that both versions induced autophagy at the molecular level, suggesting the effect is robust across variations in the diet’s exact protein content.

⁴

The researchers who conducted the human autophagy trial noted that these results are still preliminary, based on small sample sizes, and that larger studies are needed to confirm the magnitude and clinical significance of the effect. But the basic finding, that the FMD can measurably boost cellular recycling in people, not just in lab animals, is encouraging for a field that had mostly relied on rodent data.

Stem Cell Regeneration and the Refeeding Phase

Perhaps the most striking claim behind the FMD is that it promotes regeneration, essentially nudging the body to replace old or damaged cells with new ones. The evidence for this comes largely from animal studies, but the findings are dramatic enough to explain why researchers keep pursuing the idea.

In mice, four days on the fasting-mimicking diet caused multiple organs and systems to shrink in size. When the animals resumed normal eating, the researchers observed an increase in progenitor and stem cells across those systems, followed by tissue regeneration.

⁵

The pattern seems to work like this: the fasting phase forces the body to break down old and less-functional cells for energy. When food returns, the body rebuilds using newly activated stem cells. The refeeding period is not just “going back to normal.” It is an active regeneration phase. A study on pancreatic cells in mice illustrated this vividly. The FMD reduced the population of insulin-producing beta cells by about 35 percent, but within three days of refeeding, those numbers bounced back to baseline, and the regenerated cells were in a much more active, proliferative state.

⁶

The same research team traced the lineage of these new cells and found they were genuinely new beta cells derived from progenitor cells, not just old cells that had been patched up. After the FMD, these newly generated cells contributed roughly half of the overall beta-cell pool.

⁷

Whether this level of regeneration occurs in humans remains an open question. But data from clinical trials measuring biological age has been suggestive. Across two different trials, three cycles of the FMD were associated with a reduction in biological age of about two and a half years, a finding that researchers interpret as evidence that at least some regenerative processes are conserved in people.

⁸

Metabolic Health and Blood Sugar

A twelve-month randomized controlled trial integrated a fasting-mimicking diet program into primary care for people with type 2 diabetes and found meaningful improvements. Participants using the FMD lost an average of about 3.6 kilograms more than the control group over the year. Their long-term blood sugar marker, HbA1c, dropped significantly, and the need for diabetes medication decreased. Over half of FMD participants saw their blood sugar management improve, compared to only 8 percent of control participants. Meanwhile, blood sugar control worsened in 59 percent of the control group but only 23 percent of the FMD group.

⁹

A large randomized trial also measured markers across a broad population, including people not diagnosed with diabetes. A post hoc analysis showed that participants who started with elevated risk factors, such as higher BMI, blood pressure, fasting glucose, triglycerides, or cholesterol, benefited the most. In other words, the FMD seemed to help most where help was most needed, with smaller changes in people who were already metabolically healthy.

¹⁰

Fat Loss While Preserving Muscle

One concern with any calorie-restricted regimen is the risk of losing lean muscle mass along with fat. The FMD appears to sidestep this problem, at least based on the evidence available so far. A randomized trial in healthy young men found that a single FMD cycle caused an average weight loss of about 2.6 kilograms, but muscle volume, force production, and maximum voluntary contraction were entirely unaffected.

¹¹

Research specifically in people with type 2 diabetes found that 12 months of periodic FMD cycles significantly reduced visceral abdominal fat and subcutaneous abdominal fat while preserving abdominal muscle area. The visceral fat reduction was closely linked to improvements in HbA1c and other metabolic markers.

¹²

A smaller study using MRI found that three FMD cycles reduced both subcutaneous and visceral fat in overweight participants. Those who started with fatty liver disease saw their liver fat content drop by nearly 50 percent.

¹³

The pattern across these studies is consistent: the weight lost during FMD cycles comes disproportionately from fat stores, particularly the visceral fat around your organs that is most strongly linked to metabolic disease, while muscle tissue is largely spared. For people worried that periodic five-day fasting stretches would eat into their hard-earned muscle, this is reassuring, though more data in older adults and people with existing muscle loss would strengthen the picture.

Inflammation and Immune Remodeling

Chronic, low-grade inflammation underlies a wide range of diseases, from heart disease to autoimmune conditions. Multiple studies have found that FMD cycles reduce C-reactive protein, a widely used marker of systemic inflammation, particularly in people who start with elevated levels.

¹⁰

A pilot trial in periodontal disease patients explored whether the FMD could dampen inflammation in the gums. The researchers observed trends toward lower levels of CRP, inflammatory signaling molecules like IL-6, and tissue-degrading enzymes in the gum fluid of FMD participants compared to controls.

¹⁴

The anti-inflammatory effect may stem partly from how the FMD reshapes the immune system itself. White blood cell counts drop during the fasting phase as old immune cells are broken down. During refeeding, the immune system rebuilds with a fresh population of cells, a process that appears to recalibrate the overall inflammatory response.

¹⁵

Effects on the Gut Microbiome

In mouse models of inflammatory bowel disease, FMD cycles reshaped the gut microbial community in ways that appear protective. The abundance of Lactobacillaceae, a bacterial family associated with regulating immune responses and reducing IBD severity, tripled. Bifidobacteriaceae, another family linked to symptom improvement in colitis models, was uniquely enriched in the FMD-treated animals.

¹⁶

Strikingly, when researchers transplanted the fecal microbiota from FMD-treated mice into untreated mice with colitis, the recipients also showed reduced inflammation, reversed colon shortening, and increased colonic stem cells. This suggests the microbiome changes are not just a side effect of the diet but actively contribute to its regenerative and anti-inflammatory effects. Water-only fasting, by comparison, reduced some inflammatory markers in the same model but did not reverse the intestinal damage the way the FMD did.

¹⁶

Research in Cancer Treatment

The idea of using fasting alongside chemotherapy has gained traction based on a concept called differential stress resistance. When nutrients are scarce, normal cells enter a protective, low-energy state that helps them survive toxic insults. Cancer cells, driven by mutations that keep growth signals permanently switched on, cannot do this. The fasting state therefore widens the gap between how well normal cells and cancer cells tolerate chemotherapy.

The DIRECT trial, a phase 2 randomized study in breast cancer patients receiving chemotherapy before surgery, tested this idea with the ProLon FMD. Patients who used the FMD alongside chemotherapy were roughly three times more likely to have a complete or partial radiological response to treatment. Ninety-to-one-hundred-percent tumor cell loss at the time of surgery was about four times more common in the FMD group than in controls. The more FMD cycles a patient completed, the better the response.

¹⁷

Preclinical work suggests the FMD may also enhance the effects of hormone therapy in breast cancer by suppressing growth-promoting signaling pathways while boosting tumor-suppressive proteins.

¹⁸

A feasibility study in Chinese breast cancer patients undergoing chemotherapy found that the rate of serious FMD-related side effects was about 6 percent, comparable to what might be expected from chemotherapy alone.

¹⁹

Researchers remain cautious. The clinical evidence is still limited to small trials, and no one is claiming the FMD replaces conventional cancer treatment. The hope is that it can make existing treatments work better while potentially protecting healthy tissue from their side effects.

²⁰

Autoimmune Disease and Nerve Repair

Some of the most intriguing FMD research involves autoimmune conditions, where the immune system attacks the body’s own tissues. In mouse models of multiple sclerosis, FMD cycles significantly reduced disease severity, immune cell infiltration into the spinal cord, and the loss of the protective myelin sheath around nerves.

²¹

A separate study found that the FMD promoted the regeneration of oligodendrocyte precursor cells, which are the cells responsible for producing new myelin. In both chemical-damage and autoimmune models of MS, the FMD supported remyelination of nerve fibers, suggesting a dual benefit: suppressing the autoimmune attack while simultaneously helping repair the damage already done.

²²

The mechanism appears to involve a broad reset of the immune system. During the fasting phase, self-reactive immune cells, the ones attacking the body’s own tissues, are preferentially broken down. When the immune system rebuilds during refeeding, the new population is better calibrated and less prone to attacking healthy tissue. In the MS mouse models, the FMD specifically reduced the population of inflammatory T cells that drive damage in the central nervous system while boosting levels of brain-derived neurotrophic factor, a protein that supports nerve survival and growth.

²¹

Human trials exploring these autoimmune applications are still in early stages, and the clinical evidence from two separate trials showing biological age reversal suggests the regenerative effects seen in mice are at least partially conserved in humans.

⁸

Who Should Be Cautious

The FMD is not appropriate for everyone. People who are underweight, pregnant or nursing, have a history of eating disorders, or are under 18 should avoid it. Individuals with type 1 diabetes or those on insulin or blood-pressure-lowering medications need medical supervision because the metabolic shifts during the fasting phase can amplify drug effects and cause dangerous drops in blood sugar or blood pressure. The same applies to anyone on medication whose dosing depends on regular food intake.

Common side effects during the five days include fatigue, headaches, mild dizziness, and irritability, particularly on days two and three. These symptoms generally reflect the metabolic transition into a fasting state and tend to ease by day four. In the breast cancer chemotherapy study, about 6 percent of patients experienced grade three or higher adverse events related to the FMD itself, though separating diet effects from chemotherapy effects in that context is difficult.

¹⁹

A review of fasting research noted that structured fasting regimens like the FMD appear to support not just metabolic health but also neurocognitive function, mood, and psychological resilience, though these findings come from broader fasting literature rather than FMD-specific trials.

²³

Why Providing Some Food Matters More Than Eating Nothing

A reasonable question is why bother with the food at all. If fasting triggers these benefits, why not just skip eating for five days? The answer goes beyond convenience and compliance, though both matter. In the inflammatory bowel disease research, water-only fasting did reduce some inflammatory markers and boost some regenerative signals, but it failed to reverse intestinal damage the way the FMD did. The FMD’s specific nutrient composition appears to actively promote protective gut microbiome changes and stem cell activation in ways that a complete absence of food does not.

¹⁶

There is also the practical reality that a water-only fast lasting five days is genuinely difficult and carries risk of muscle breakdown, electrolyte imbalances, and dangerous drops in blood pressure, especially when done repeatedly. The FMD keeps those risks manageable while maintaining the low nutrient signaling that drives the cellular benefits. For cancer patients, this distinction is especially relevant. Researchers have described FMDs as safer and less challenging options compared to water-only fasting or chronic dietary restriction.

The science on the fasting-mimicking diet is still maturing. Most of the regenerative findings come from animal models, and while the metabolic and body composition results in humans are consistent and encouraging, the trials have been relatively small. What makes the FMD research genuinely interesting, rather than just another diet trend, is that it provides a mechanistic story connecting fasting to stem cell activation, immune remodeling, and tissue repair, all through a protocol that real people can realistically follow several times a year.